Cargando…
ProfhEX: AI-based platform for small molecules liability profiling
Off-target drug interactions are a major reason for candidate failure in the drug discovery process. Anticipating potential drug’s adverse effects in the early stages is necessary to minimize health risks to patients, animal testing, and economical costs. With the constantly increasing size of virtu...
Autores principales: | Lunghini, Filippo, Fava, Anna, Pisapia, Vincenzo, Sacco, Francesco, Iaconis, Daniela, Beccari, Andrea Rosario |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10251600/ https://www.ncbi.nlm.nih.gov/pubmed/37296454 http://dx.doi.org/10.1186/s13321-023-00728-6 |
Ejemplares similares
-
Ensemble of structure and ligand-based classification models for hERG liability profiling
por: Vittorio, Serena, et al.
Publicado: (2023) -
“Molecular Anatomy”: a new multi-dimensional hierarchical scaffold analysis tool
por: Manelfi, Candida, et al.
Publicado: (2021) -
The economics of platform liability
por: Lefouili, Yassine, et al.
Publicado: (2022) -
When Does Physician Use of AI Increase Liability?
por: Tobia, Kevin, et al.
Publicado: (2021) -
Autonomous AI systems in the face of liability, regulations and costs
por: Saenz, Agustina D., et al.
Publicado: (2023)